| Quantity: | |
|---|---|
FY-P022
The OEM V1 75U Semaglutide Injection Pen is a premium drug delivery device tailored for GLP-1 therapies such as semaglutide, liraglutide, and other peptide-based medications. Designed with precision engineering and patient-centric ergonomics, it offers accurate dosing, high compatibility, and full OEM customization to support pharmaceutical partners worldwide.
Extended Capacity & Accurate Dosing
Supports up to 75 units per cartridge, making it suitable for higher-dose therapies.
Ensures precise and consistent dosing to reduce risks of under- or overdosing.
Customizable Dose Scale
Fully customizable dose markings (units, increments, visibility levels) to match specific drug protocols.
Enhanced readability for elderly or visually impaired patients.
Branding opportunities through unique scale designs tailored to pharmaceutical partners.
High Drug Compatibility
Optimized for semaglutide and other GLP-1 peptide formulations.
Compatible with 3ml standard cartridges compliant with ISO11608-3.
Suitable for various biologics and chronic disease treatments requiring injectable delivery.
OEM/ODM Solutions
Exterior design, colors, logos, textures, and finishes can be fully customized.
Flexible branding and packaging solutions that help partners achieve market differentiation.
One-stop service including matching cartridges, pen cases, and injection needles.
Ergonomic V1 Design
Features the classic pen clip structure, offering portability and ease of use.
Smooth injection mechanism reduces injection anxiety and improves patient comfort.
Regulatory Compliance & Quality
Developed in compliance with ISO11608-1/2/3 standards.
Tested for durability through environmental stress testing, drop testing, vibration testing, and aging validation.
With over 10 years of expertise in injection system manufacturing, Sunrise offers more than just a device. We deliver precision-engineered, customizable, and globally compliant solutions that empower pharmaceutical partners to launch innovative therapies with confidence.
The OEM V1 75U Semaglutide Injection Pen combines scalable customization, broad drug compatibility, and proven safety — making it the ideal choice for next-generation GLP-1 drug delivery.
The OEM V1 75U Semaglutide Injection Pen is a premium drug delivery device tailored for GLP-1 therapies such as semaglutide, liraglutide, and other peptide-based medications. Designed with precision engineering and patient-centric ergonomics, it offers accurate dosing, high compatibility, and full OEM customization to support pharmaceutical partners worldwide.
Extended Capacity & Accurate Dosing
Supports up to 75 units per cartridge, making it suitable for higher-dose therapies.
Ensures precise and consistent dosing to reduce risks of under- or overdosing.
Customizable Dose Scale
Fully customizable dose markings (units, increments, visibility levels) to match specific drug protocols.
Enhanced readability for elderly or visually impaired patients.
Branding opportunities through unique scale designs tailored to pharmaceutical partners.
High Drug Compatibility
Optimized for semaglutide and other GLP-1 peptide formulations.
Compatible with 3ml standard cartridges compliant with ISO11608-3.
Suitable for various biologics and chronic disease treatments requiring injectable delivery.
OEM/ODM Solutions
Exterior design, colors, logos, textures, and finishes can be fully customized.
Flexible branding and packaging solutions that help partners achieve market differentiation.
One-stop service including matching cartridges, pen cases, and injection needles.
Ergonomic V1 Design
Features the classic pen clip structure, offering portability and ease of use.
Smooth injection mechanism reduces injection anxiety and improves patient comfort.
Regulatory Compliance & Quality
Developed in compliance with ISO11608-1/2/3 standards.
Tested for durability through environmental stress testing, drop testing, vibration testing, and aging validation.
With over 10 years of expertise in injection system manufacturing, Sunrise offers more than just a device. We deliver precision-engineered, customizable, and globally compliant solutions that empower pharmaceutical partners to launch innovative therapies with confidence.
The OEM V1 75U Semaglutide Injection Pen combines scalable customization, broad drug compatibility, and proven safety — making it the ideal choice for next-generation GLP-1 drug delivery.
